Search Results (13,881)

Background/Objectives: Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer worldwide, with a steadily increasing incidence in aging populations, particularly among older and immunocompromised individuals. Early-stage cSCC disease is usually managed with surgery or radiotherapy; however, advanced or unresectable cases remain therapeutically challenging. The advent of immune checkpoint inhibitors (ICIs), especially programmed cell death protein 1 inhibitors, such as cemiplimab and pembrolizumab, has markedly improved outcomes in advanced cSCC. Nevertheless, resistance to immunotherapy, management of frail or super-aged patients, and optimal integration of systemic therapy with radiotherapy continue to pose important clinical questions. Methods: This review provides an updated overview of the current treatment strategies for cSCC, with particular attention to recent advances in systemic therapy and the application of geriatric oncology principles. We emphasize the considerations relevant to East Asian practices, especially in Japan, where the demographic shift toward a super-aged society magnifies the need for tailored approaches. Results: Although most pivotal clinical trials have been conducted in Western populations, emerging real-world data from East Asia have demonstrated comparable efficacy and safety of ICIs, underscoring the global relevance of immunotherapy in diverse patient groups. By incorporating a structured frailty assessment, individualized treatment goals, and proactive management of immune-related adverse events, this review highlights practical strategies for optimizing cSCC care in older patients. Conclusions: Future directions include predictive biomarker development; refinement of treatment sequencing; and multidisciplinary collaboration among oncology, dermatology, and geriatrics to adapt cSCC management to aging societies. Full article

Background: Improvements in cancer detection and treatment have led to a growing population of cancer survivors who subsequently develop cardiovascular (CV) disease requiring cardiac surgery. Methods: This narrative review synthesizes contemporary evidence from observational studies, registries, meta-analyses, and international guidelines addressing cardiac surgery in patients with active or prior cancer. Results: Cancer patients undergoing cardiac surgery face heightened risks related to hypercoagulability, bleeding, immunosuppression, frailty, and prior exposure to chemotherapy or radiotherapy. Conventional surgical risk scores inadequately capture cancer-specific factors such as tumor biology, prognosis, treatment trajectory, and frailty, often underestimating operative risk. Timing of surgery must balance CV urgency against oncologic priorities, with urgent cardiac conditions necessitating prompt intervention irrespective of cancer status, while stable disease allows individualized sequencing. Transcatheter and minimally invasive approaches increasingly play a key role, particularly in patients with limited life expectancy, hostile thoracic anatomy, or high surgical risk. Outcomes are heterogeneous and largely driven by cancer stage and prognosis rather than cardiac pathology alone. Conclusions: Cardiac surgery can be lifesaving and restore eligibility for definitive oncologic therapy in carefully selected patients, particularly those with early-stage or potentially curable malignancies. In advanced cancer, the benefits of invasive intervention must be weighed against perioperative burden, quality of life impact, and overall prognosis. Multidisciplinary, patient-centered decision-making within specialized cardio-oncology teams is essential. Future priorities include the development of cancer-specific risk prediction models, prospective surgical registries, and greater integration of quality-of-life outcomes into clinical decision-making. Full article

Inherited platelet disorders (IPDs) comprise a heterogeneous group of rare conditions that present particular challenges during pregnancy, with bleeding risk increasing during labor and the immediate postpartum period. These disorders require coordinated, multidisciplinary management to mitigate maternal and neonatal bleeding risk. Although data remains limited, individuals with IPD, including Bernard–Soulier syndrome, Glanzmann thrombasthenia, MYH9-related disorders, Hermansky–Pudlak syndrome, and platelet storage pool disorders, are at an increased risk for obstetrical bleeding, with the degree of risk varying by underlying diagnosis. In severe inherited platelet disorders such as Glanzmann thrombasthenia, peripartum hemorrhage is common, with up to half of the deliveries in some series requiring red cell or platelet transfusion. Because these conditions are congenital, the fetus may also be affected, placing neonates at risk for serious bleeding complications, including intracranial hemorrhage, although available data is limited. Despite the considerable morbidity and mortality risk associated with inherited platelet disorders, management strategies during pregnancy and delivery remain poorly defined. This stands in contrast to other bleeding disorders, such as factor deficiencies, for which multiple therapeutic approaches have been evaluated in the peripartum setting. In this review, we summarize the available evidence and current management strategies for individuals with inherited platelet disorders during pregnancy and delivery. Full article

Background and Objectives: To evaluate pregnancy outcomes and transthoracic echocardiographic (TTE) findings during the antenatal and postpartum periods in women with repaired Tetralogy of Fallot (ToF) who delivered at Çukurova University Faculty of Medicine, Balcalı Hospital, between 2011 and 2025 and to interpret these findings in the context of the 2025 European Society of Cardiology (ESC) recommendations. Materials and Methods: This single-center retrospective cohort study undertaken between 2011 and 2025 included 11 pregnant women with surgically repaired ToF. Maternal demographic characteristics, obstetric outcomes, mode of delivery, neonatal outcomes, and antenatal TTE parameters were recorded. Cardiac measurements obtained during pregnancy were compared with postpartum TTE findings performed 3–6 months after delivery to assess pregnancy-related cardiac adaptation and recovery. Results: A total of 11 pregnancies in women with repaired ToF were analyzed. Nine pregnancies resulted in live births, while one ended in missed abortion at 9 + 2 weeks and one in intrauterine fetal demise at 34 + 2 weeks. Among live births, the mean gestational age was 36 + 2 weeks and the mean birthweight was 2865 g, with a preterm delivery rate of 55.6%. Cesarean section was performed in 70% of cases, while 30% delivered vaginally. During pregnancy, the mean left ventricular ejection fraction was 62.6%, and residual tricuspid regurgitation was the most frequently observed echocardiographic finding. Postpartum TTE evaluations indicated that echocardiographic parameters were largely stable over the observation period, with no numerical change and no clear evidence of deterioration in ventricular function or progression of valvular regurgitation. Conclusions: Despite successful surgical repair, pregnancy may still pose potential risks for women with ToF, underscoring the importance of individualized, multidisciplinary management. In this cohort, pregnancy appeared to be generally well-tolerated when care was provided in accordance with contemporary ESC recommendations. The observation of preserved ejection fraction and overall stable right ventricular function in the early postpartum period suggests that favorable maternal cardiac adaptation may be achievable in carefully selected patients. Early postpartum echocardiographic assessment may be useful for identifying functional changes and informing structured long-term follow-up strategies. Full article

Eye diseases, such as glaucoma, diabetic retinopathy, and age-related macular degeneration, drive the growing need for reliable and scalable analyses of fundus and optical coherence tomography (OCT) images. Deep learning performs strongly in ocular structure segmentation. However, it typically relies on dense pixel-wise annotations, which are costly and difficult to obtain at scale. Weakly supervised learning (WSL) can reduce this burden by leveraging coarse labels, limited strong annotations, and unlabeled data. This systematic umbrella review synthesizes survey and review articles on weakly supervised deep learning for image segmentation, with a focus on ocular imaging (fundus and OCT/OCTA). After analyzing twenty-one secondary studies, the main finding reveals an “empty intersection”: WSL-focused segmentation surveys are often modality-agnostic. Conversely, ocular reviews are predominantly fully supervised and seldom offer quantitative evidence on annotation-effort savings or direct comparisons between weak and fully supervised methods on identical datasets. Across the included reviews, label-efficient strategies cluster around CAM/MIL formulations, sparse supervision (points/scribbles/boxes), pseudo-labelling/self-training, and semi-/self-supervised learning, implemented mainly with U-Net/DeepLab families and increasingly Transformer or hybrid backbones. These results provide a structured map of available WSL mechanisms and, critically, identify reproducible reporting gaps that currently prevent fair benchmarking in ocular segmentation. Therefore, this review supports the development of ocular-specific benchmarks and minimum reporting practices that link segmentation performance to annotation effort. Full article

Background/Objectives: Chronic limb-threatening ischemia (CLTI) is a severe form of peripheral artery disease characterized by ischemic rest pain or ulcer necrosis. In Europe, spinal cord stimulation (SCS) can be offered to CLTI patients with chronic pain to improve mobility and prolong limb preservation. We evaluated the long-term, real-world outcomes of SCS therapy in patients with CLTI. Methods: In this observational study, medical chart review data from consecutive CLTI patients treated with SCS were analyzed. Results: Fifty-three patients (56.6% Fontaine Stage III, 39.6% Fontaine Stage IV, 3.8% Fontaine Stage IIb) had a single-stage SCS implant procedure between 2013 and 2022. Two years after SCS therapy activation, claudication pain intensity had significantly improved; the overall numerical rating scale pain score decreased from 9.4 ± 0.9 at baseline to 3.7 ± 3.2 (p < 0.0001). In addition, walking distance increased by more than 350 m (from 70 ± 87 to 429 ± 320 m, p < 0.0001), and pre-existing skin lesions stabilized in ten patients (63%). The probability of limb survival in Fontaine’s stage IIb/III and Fontaine’s stage IV patients at 12 months was 90% and 70%, respectively (log-rank p-value = 0.04). Finally, significant associations were found between the occurrence of an amputation after SCS and Fontaine Stage (p = 0.01), active smoking (p = 0.02), hypertension (p = 0.04), and prior minor amputation (p = 0.02). No major complications were reported. Conclusions: Our real-world experience suggests that SCS for CLTI patients provides significant and durable improvements in ischemic pain and functional outcomes. SCS may also help reduce the natural risk of major amputation, especially when implemented at early CLTI stages. Full article

Background/Objectives: Comorbidity and risk factor management and avoiding stroke are pillars of optimal atrial fibrillation management. In this article, the latest literature on additional stroke risk factors not included in the CHA₂DS₂-VA score is reviewed in patients with non-valvular atrial fibrillation (NVAF). The possible clinical impacts of the additional risk factors in NVAF patients with a CHA₂DS₂-VA score of 1 are compiled with insights in an interdisciplinary panel discussion to refine daily clinical practice. Methods: The panel was composed of three cardiologists, one endocrinologist, and a nephrologist. The panel members finalized twenty open-ended questions covering major problems in stroke risk stratification in NVAF patients with a score of 1. The shortcomings of this clinical-based model for stroke prevention and its possible outcomes were discussed with evidence-based recommendations. The meeting outcomes are addressed for daily clinical adaptation in the present article. Results: Recent evidence suggests that the CHA₂DS₂-VA score may have shortcomings in a striking rate of NVAF patients with a score of 1. The growing body of evidence suggests that combining clinical, laboratory, and imaging predictors with the CHA₂DS₂-VA score may further refine stroke risk prediction and aid in decision-making for anticoagulation of NVAF patients with a score of 1. Conclusions: The interdisciplinary expert panel offered several recommendations based on the assessment of additional risk factors, which may enable clinicians to identify individualized patient characteristics and early multidisciplinary prevention of disease progression and personalized improvements in the long-term cardiovascular outcomes in NVAF patients with a CHA₂DS₂-VA score of 1. Full article

Background and Objectives: Chronic spontaneous urticaria (CSU) significantly affects patients’ quality of life (QoL) and remains challenging to manage, particularly in under-researched regions. This study aimed to assess the clinical burden, disease control, and quality of life among patients with CSU in Kazakhstan and to identify predictors of severe disease activity. Materials and Methods: We conducted a cross-sectional study of 350 patients with CSU attending the Republican Allergy Center in Almaty between December 2024 and June 2025. Patients were classified based on the presence of co-existing chronic inducible urticaria (CIndU), angioedema, or both. Disease activity, control, and QoL were assessed using the Urticaria Activity Score over 7 days (UAS7), Urticaria Control Test (UCT), and Dermatology Life Quality Index (DLQI), respectively. Multivariable logistic regression and correlation analyses were used to identify predictors of severe disease and interrelationships among clinical measures. Results: Among 350 patients (mean age 43.5 ± 14.7 years; 78% female), 46.3% had CSU alone, while 53.7% had associated phenotypes. Severe urticaria (UAS7 ≥ 28) affected 30% of patients. Suboptimal disease control (UCT ≤ 11) was reported in 30%, and 30% experienced strong or very strong QoL impairment (DLQI > 10). Older disease onset (≥60 years; OR = 1.98; 95% CI: 1.02–3.81) and nighttime symptoms (OR = 1.67; 95% CI: 1.02–2.73) were independently associated with severe disease. A strong inverse correlation was observed between UAS7 and UCT (ρ = −0.71), and a positive correlation between UAS7 and DLQI (ρ = 0.66), highlighting the impact of disease activity on control and QoL. Conclusions: CSU imposes a substantial clinical and psychosocial burden in Kazakhstan. One-third of patients experience severe symptoms and impaired QoL despite ongoing treatment. Older age at disease onset and nighttime symptoms may serve as practical indicators of disease severity. These findings highlight the need for improved access to advanced therapies, systematic monitoring using validated tools, and multidisciplinary care strategies in resource-constrained settings. Full article

Background/Objectives: The management of mycotic aortic aneurysm and aortic graft infection is complex, and the pathology is rare. Over the past decade, we have developed a high-volume multidisciplinary service and comprehensive management algorithm. We intend to report on our experience and management strategy. Methods: We have examined the different aspects of the service, how it was developed, the standardisation of management, and its impact on consistent decision-making. Discussion: Low-volume, high-complexity pathologies are challenging and infrequently reported in the literature. The growth of our service and experience has improved outcomes and allowed for timely and consistent decision-making. We believe a central, multidisciplinary, standardised approach allows for prospective data collection and analysis. Although mycotic aortic aneurysm and aortic graft infection are discrete pathologies, our management algorithm and dedicated aortic infection service provides a comprehensive management strategy for both conditions. Conclusions: A comprehensive management algorithm has not previously been described by a tertiary centre. We have demonstrated that a unique multidisciplinary clinical approach and dedicated specialist service following a standardised management algorithm delivers superior patient outcomes. Whilst our basic management algorithm has remained largely intact over the years, we anticipate change in the future based upon emerging high-quality evidence and our own experience. Full article

Background: The role of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) management has evolved over recent years. Although it appears that the overall number of procedures is declining, international guidelines now endorse TACE beyond the Barcelona Clinic Liver Cancer (BCLC) intermediate stage, and multiple TACE platforms allow patient-tailored treatments. In this context, degradable starch microspheres TACE (DSM-TACE) may be valuable when the goal is to preserve liver function and spare healthy parenchyma. This study reports multicenter retrospective Italian data to assess the efficacy and safety of DSM-TACE with EmboCept^® in patients with early-to advanced-stage HCC, and to evaluate whether procedural selectivity (superselective vs. lobar) influences outcomes. Methods: This retrospective multicenter study included 201 patients initially; after applying exclusion criteria, 187 patients (334 HCC nodules) treated across eight centers (2014–2024) were analyzed. Treatment indications were discussed in multidisciplinary tumor boards in all centers. Superselective DSM-TACE was performed in 48 patients (66 nodules, 19.8%), while 139 patients (268 nodules, 80.2%) underwent a lobar approach. Repeated sessions were performed on demand and recorded for lobar treatments. Tumor response was assessed using mRECIST criteria at 1, 3–6, 6–9, and 9–12 months; adverse events were classified according to the Common Terminology Criteria for Adverse Events (CTCAE). efficacy and safety outcomes were compared according to the DSM-TACE approach. Results: In terms of safety, analysis confirmed the overall good tolerability of DSM-TACE, with no grade ≥ 3 adverse events and no major complications or procedure-related deaths. No significant differences were observed in post-embolization syndrome (PES) rates between groups. With regard to efficacy, for the entire cohort, the overall response rate (ORR) was 70% at 1 month, 31.6% at 3–6 months, 20.5% at 6–9 months, and 13.5% at 9–12 months, while the disease control rate (DCR) was 91.4% at 1 month, 69% at 3–6 months, 38.6% at 6–9 months, and 27% at 9–12 months. At intermediate follow-up, superselective DSM-TACE achieved higher ORR than lobar treatment at 3–6 months (53.8% vs. 26.4%; p = 0.009) and 6–9 months (43.8% vs. 15.3%; p = 0.009). Per-nodule analysis confirmed this advantage at 3–6 months (ORR = 66.7% vs. 31.3%; p = 0.0008). Conclusions: DSM-TACE with EmboCept^® provides favorable tumor control and a good safety profile in routine clinical practice. A superselective approach is associated with improved response at intermediate follow-up compared with lobar strategy, supporting DSM-TACE as a flexible therapeutic option for localized HCC. Full article

This paper presents paper-based dye-sensitized solar cells (paper DSSCs) fabricated using carbon nanotube (CNT) composite paper produced from mixtures of CNT and pulp dispersions. DSSC is composed of a dye-adsorbed semiconducting electrode, a counter electrode, and an electrolyte. In this study, our DSSC is constructed using n-type semiconducting CNT composite paper as the semiconducting electrode, metallic CNT composite paper as the counter electrode, and ordinary paper for keeping the electrolyte. In our previous study, potassium hydroxide was used to convert semiconducting CNT composite paper to n-type, but the performance was limited. Therefore, we aim to achieve a more stable and higher-performing paper DSSC by annealing the semiconducting CNT composite paper in a hydrogen–argon atmosphere to induce n-type properties. For this, CNT composite paper was prepared using the cationic surfactants DODMAC( dimethyl octadecyl ammonium=chloride, cationic surfactant) and DDAC as dispersing agents. The fabricated DSSCs were evaluated in terms of photoelectric conversion efficiency and fill factor (FF). As a result, DSSCs using DODMAC increased the efficiency from 5.04 × 10⁻³% to 13.37 × 10⁻³% and the FF from 0.13 to 0.21. When DDAC was used, the efficiency increased to 17.11 × 10⁻³% and the FF improved to 0.27. Full article

The reconstruction of biological profiles from aged or degraded human skeletal remains represents a major challenge in both forensic and bioarcheological contexts, particularly when conventional identification approaches fail. Recent advances in molecular genetics, biochemical and histological analyses, and biomolecular anthropology have substantially expanded the range of information that can be recovered from compromised remains. This review synthesizes current integrative approaches combining genomic analyses, stable isotope investigations, epigenetic age estimation, proteomic sex determination, and complementary histological techniques to infer sex, ancestry, kinship, age, diet, mobility, and geographic origin. Genetic methods, including next-generation sequencing (NGS), enable increasingly robust inference even from highly degraded samples. Stable isotope analyses provide insights into dietary patterns and mobility, while DNA methylation markers improve age estimation accuracy. Tooth cementum annulation (TCA), although a histological rather than molecular method, contributes an additional chronological indicator within an integrative analytical framework. Rather than treating these approaches independently, this review proposes a multidisciplinary perspective in which complementary datasets collectively support biological profile reconstruction. Integrative interpretation enhances identification potential and provides more nuanced life-history reconstructions, demonstrating the value of combining molecular, biochemical, and histological evidence in forensic and archaeological investigations. Full article

The accurate determination of the rheological properties of road bitumen types is essential for the reliable prediction of long-term pavement behaviour. At 60 °C, dynamic viscosity is a key rheological parameter characterising the shear-dependent viscoelastic behaviour of bitumen in the temperature range relevant to in-service pavement loading. This study aims to compare different viscosity determination methods—approximations, capillary viscosity, Brookfield measurement and complex viscosity determined by a dynamic shear rheometer (DSR)—and to analyse their relationships with each other in order to find the best method for bitumen classification. Furthermore, the European and Australian bitumen classification standards are compared in terms of dynamic viscosity and penetration, according to which Australian bitumen types show more stable results, as the CV% is less than 10 percent. The study is based on the testing of Hungarian paving-grade bitumens (B50/70, B70/100) and Australian viscosity-graded bitumens (C170, C320), with the comparison of a total of 191 samples obtained from industrial production. The statistical evaluation of the results obtained with the different methods was based on Pearson correlation analysis and relative deviation analysis. The results indicate that the DSR measurement at 1.6 Hz shows the closest agreement with capillary viscosity, with a linear correlation coefficient of 0.95, and exhibits the strongest overall correlation with the other measurement approaches, whereas the Heukelom equation tends to overestimate the dynamic viscosity. The Brookfield method yielded higher viscosity values in all tests. The study highlights that the results of different measurement methods can only be compared under specific shear conditions, and a DSR-based approach can be more suitable for the introduction of a new European bitumen classification system. Full article

Background and Objectives: Soft tissue regeneration in oral surgery has undergone remarkable progress in the last decade, supported by the development of innovative laser technologies, advanced biomaterials, platelet-rich plasma (PRP), mesenchymal stem cells (MSCs), and three-dimensional (3D) printing. Lasers are increasingly used not only for incision and coagulation but also for photobiomodulation, promoting cellular proliferation, angiogenesis, and tissue healing. The purpose of this review is to analyze the current advances in soft tissue regeneration, with a particular focus on the clinical use of lasers and their integration with other regenerative strategies. In parallel, hard tissue regeneration has evolved through the synergistic use of bioactive scaffolds, recombinant human growth factors (rhBMP-2, rhPDGF-BB), MSCs, and 3D-printed constructs. These innovations have enhanced alveolar bone regeneration, implant osseointegration, and periodontal tissue repair, offering predictable clinical outcomes. Materials and Methods: A review of the literature published between 2015 and 2025 was conducted through PubMed, Scopus, Web of Science, Embase, and Google Scholar. Clinical and preclinical studies on the use of CO₂, Nd:YAG, Er:YAG, diode, and 445 nm lasers, biomaterials, PRP, MSCs, growth factors, and 3D-printed scaffolds were included. Results: Laser applications demonstrated significant benefits in epithelialization, biostimulation, and reduction in postoperative discomfort in soft tissues. For hard tissues, the combined use of MSCs, bioactive scaffolds, and growth factors promoted osteogenic differentiation, bone volume preservation, and improved mechanical stability. Photobiomodulation enhanced osteoblastic activity and accelerated bone remodeling, while 3D-printed scaffolds provided personalized architecture for optimal integration. Conclusions: Regenerative approaches integrating lasers, biomaterials, PRP, MSCs, growth factors, and 3D printing represent safe, minimally invasive, and effective strategies for the regeneration of both soft and hard oral tissues. These multidisciplinary techniques improve healing quality, functional recovery, and esthetic outcomes, reflecting the growing trend toward precision and technology-driven regenerative oral surgery. Full article

Wind instrument performance requires sustained and repetitive increases in intrathoracic and pharyngeal pressures, which may lead to rare but clinically relevant anatomical alterations of the upper aerodigestive tract. We report the case of a 46-year-old male semi-professional wind instrument player who developed massive hypopharyngeal dilatation and cervical lung herniation as a consequence of long-term, high-pressure musical activity. Dynamic imaging performed during instrument playing demonstrated marked hypopharyngeal expansion and herniation of the lung apices into the cervical region, highlighting the importance of individualized diagnostic strategies that replicate patient-specific triggers. Multidisciplinary evaluation integrating otorhinolaryngology, thoracic surgery, radiology, and pulmonology led to a personalized risk assessment and the recommendation to cease wind instrument performance in order to prevent potentially life-threatening complications, such as pneumothorax. This case illustrates how personalized diagnostic approaches and tailored clinical decision-making are essential in managing rare occupational conditions. A comprehensive review of the literature is provided, with a focus on individualized risk factors, diagnostic strategies, and personalized treatment concepts relevant to precision medicine. Full article